Asif Ali - 18 Apr 2023 Form 4 Insider Report for Protagonist Therapeutics, Inc (PTGX)

Role
Chief Financial Officer
Signature
/s/ Matthew Gosling, Attorney-in-Fact for Asif Ali
Issuer symbol
PTGX
Transactions as of
18 Apr 2023
Net transactions value
-$27,597
Form type
4
Filing time
19 Apr 2023, 16:28:50 UTC
Previous filing
18 Jan 2023
Next filing
02 Jun 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PTGX Common Stock Tax liability $27,597 -1,189 -4.9% $23.21 23,186 18 Apr 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the release of 3,437 vested restricted stock units on April 18, 2023.
F2 The shares of common stock reported on this Form 4 are subject to a lock-up agreement between the reporting person and J.P. Morgan Securities LLC, Jefferies LLC and Piper Sandler & Co., dated April 4, 2023 (the "Lock-up Date") pursuant to which the shares of common stock reported herein cannot be sold for 60 days following the Lock-up Date.